Nabta Health is proud to announce its selection as the Best AI Startup and Best Overall Startup at the Accenture Innovation Cup as part of the GITEX Future Stars, where Nabta was selected from 750 different companies from across the Middle East and North Africa Region.
The awards come with fast-tracking for the Expo2020 Innovation Grant Program and an all-expenses-paid trip to Silicon Valley to meet with investors and potential partners courtesy of Accenture.
The Nabta team will continue to be present at Gitex Dubai this week and can be visited at stand G35 where we have been received with much interest from Gitex attendees as we continue to reimagine women's health through our updated Nabta Cycle application.
About Nabta Health – “Empowering Women Worldwide”
Nabta Health is the first dedicated platform for women’s health in the Middle East and North Africa. Its mission is to empower the 170 million women in the Arab world to more effectively manage their health and the health of their families.
Nabta provides a comprehensive set of digital health services to women, which mirror the health-related challenges and concerns that accompany every major event in their lives; from birth, through puberty, marriage, and pregnancy, to parenting, perimenopause and beyond.
Nabta’s digital platform brings much-needed transparency and access to women in the MENA region. It promises privacy and security to women trapped by a culture of shame and enables them to be proactive about their health.
More than simply providing privacy to women, however, Nabta uses proprietary technology to create a “Health 3.0” experience for women, featuring hybrid healthcare provision, personalized health insights from an artificially intelligent healthcare assistant, and blockchain-based Electronic Health Records (EHRs).
Nabta’s flagship product, Nabta Cycle, allows women to monitor all aspects of their reproductive health including the different phases of their menstrual cycle. Nabta Cycle is integrated with a real-time fertility monitor for 99% accurate ovulation prediction, detection of anovulatory cycles, and alerts regarding potential fertility issues. The fertility monitor is FDA-approved and CE certified.
© Press Release 2018